Browse studies
Find your next paid study
3 recruiting studies matching your filters
The SUPRAMAX-study: Supramaximal Resection Versus Maximal Resection for High-Grade Glioma Patients (ENCRAM 2201)
A greater extent of resection of the contrast-enhancing (CE) tumor part has been associated with improved outcomes in high-grade glioma patients. Recent result…
GlioblastomaHigh-grade GliomaGlioblastoma, IDH-wildtype+9 more
Jasper GerritsenNCT06118723
Phase 1
Phase I/II Trial of Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma
Primary brain cancer kills up to 10,000 Americans a year. These brain tumors are typically treated by surgery, radiation therapy and chemotherapy, either indiv…
GlioblastomaBrain CancerBrain Neoplasm+4 more
Northwell HealthNCT02861898
Phase 2
Phase II Trial of Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory Glioblastoma Multiforme, Anaplastic Astrocytoma, and Anaplastic Oligoastrocytoma
Primary brain tumors are typically treated by surgery, radiation therapy and chemotherapy, either individually or in combination. Present therapies are inadequ…
GlioblastomaAnaplastic AstrocytomaAnaplastic Oligoastrocytoma+6 more
Northwell HealthNCT02800486